Aspen Aerogels (NYSE:ASPN) Updates Q1 2025 Earnings Guidance

Aspen Aerogels (NYSE:ASPN) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.180-0.000 for the period, compared to the consensus earnings per share estimate of 0.080. The company issued revenue guidance of $75.0 million-$95.0 million, compared to the consensus revenue estimate of $104.2 million.

Aspen Aerogels Stock Performance

NYSE ASPN traded down $0.36 during trading hours on Friday, hitting $8.64. 628,120 shares of the stock were exchanged, compared to its average volume of 1,963,723. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock has a 50-day moving average of $12.36 and a 200 day moving average of $18.63. Aspen Aerogels has a 12-month low of $8.43 and a 12-month high of $33.15. The company has a market cap of $709.24 million, a price-to-earnings ratio of 878.18 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. As a group, equities research analysts forecast that Aspen Aerogels will post 0.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ASPN shares. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Craig Hallum cut their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday. Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, Barclays cut their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $26.33.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.